SEC Form D · Amendment · filed September 13, 2024
Biolinq Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (27)
Jared A. Tangney · SAN DIEGO, CAExecRichard Yang · SAN DIEGO, CAExec · DirectorDerek Rapp · SAN DIEGO, CADirectorThad Johnson · SAN DIEGO, CADirectorZina A. Besse · SAN DIEGO, CADirectorChris Dimitropoulos · SAN DIEGO, CADirectorDan Bradbury · SAN DIEGO, CADirectorDavid A. Arida · SAN DIEGO, CAExecDavid A. Berry · SAN DIEGO, CADirectorDerek Rapp · SAN DIEGO, CADirectorChris Dimitropoulos · SAN DIEGO, CADirectorDan Bradbury · SAN DIEGO, CADirectorRichard Yang · SAN DIEGO, CAExec · DirectorThad Johnson · SAN DIEGO, CADirectorZina A. Besse · SAN DIEGO, CADirectorDavid A. Berry · SAN DIEGO, CADirectorDavid A. Arida · SAN DIEGO, CAExecJared A. Tangney · SAN DIEGO, CAExecSunil Chhaya · Palo Alto, CAExecPhilip Cockriel · Arlington, TXDirectorMark J. Pate · KNOXVILLE, TNExecGeorge Bashforth · Grand Cayman, Cayman IslandsDirectorJeffrey M. Smith · San Francisco, CADirectorStepchange Fund I GP, LLC · Seattle, WAExec · DirectorArmaan Ali · San Francisco, CADirectorMort Bloomberg · Jerusalem, L3DirectorJorn Vicari · San Francisco, CADirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗